Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,909
Closed -$534K 88
2025
Q3
$534K Sell
7,909
-1,103
-12% -$73.2K 0.12% 85
2025
Q2
$587K Buy
9,012
+2,266
+34% +$136K 0.14% 74
2025
Q1
$417K Buy
6,746
+1,293
+24% +$85.7K 0.11% 101
2024
Q4
$393K Buy
5,453
+418
+8% +$32.7K 0.1% 102
2024
Q3
$410K Sell
5,035
-174
-3% -$13.9K 0.15% 89
2024
Q2
$387K Buy
5,209
+1,423
+38% +$107K 0.1% 97
2024
Q1
$295K Buy
3,786
+193
+5% +$14.4K 0.08% 110
2023
Q4
$257K Buy
3,593
+29
+0.8% +$2.02K 0.08% 114
2023
Q3
$247K Buy
3,564
+344
+11% +$26K 0.1% 100
2023
Q2
$261K Buy
+3,220
New +$263K 0.1% 102

Other funds holding HOLX

Humankind Investments's HOLX Position: Q4 2025 in Review

Humankind Investments sold out of Hologic (HOLX) in Q4 2025, closing a stake of 7,909 shares — an estimated $534K sold.

Humankind Investments first reported a position in HOLX in Q2 2023 and held it in 10 quarters. The position peaked at $587K in Q2 2025. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Humankind Investments reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 7,909 Hologic shares in Q4 2025, an estimated $534K.
  • Humankind Investments first reported a position in Hologic in Q2 2023 and held it in 10 quarters.
  • Humankind Investments's Hologic position peaked at $587K in Q2 2025.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.